Volume 28, Number 9—September 2022
Research
Quantifying Population Burden and Effectiveness of Decentralized Surveillance Strategies for Skin-Presenting Neglected Tropical Diseases, Liberia
Table 1
Disease | Total no. cases | Crude prevalence/10,000 persons (95% CI) | Design-adjusted population prevalence/10,000 persons (95% CI) | Median age, y | Female, % | Cluster prevalence range/10,000 persons | ICC† |
---|---|---|---|---|---|---|---|
All skin NTDs |
236 |
41.5 (36.2–46.8) |
34.0 (29.1–38.9) |
42 |
42.3 |
0‒330 |
0.27 |
Buruli ulcer |
4 |
0.7 (0.1–1.4) |
0.9 (0–1.8) |
16.5 |
50.0 |
0–39.4 |
NA |
Leprosy |
39 |
6.9 (4.7–9.0) |
4.4 (3.3–5.5) |
44 |
42.8 |
0–74.1 |
0.18 |
LF lymphedema |
111 |
19.5 (15.9–23.2) |
17.5 (14.1–21.0) |
48 |
67.3 |
0–209.7 |
0.41 |
LF hydrocele |
58 |
10.2 (7.6–12.8) |
8.5 (4.8–12.3) |
43 |
0 |
0–256.4 |
0.43 |
Active yaws | 24 | 4.2 (2.5–5.9) | 2.6 (1.4–3.9) | 10 | 25.0 | 0‒205 | 0.93 |
*Age and sex data were missing for 9 skin NTD cases. ICC, intraclass correlation coefficient; LF, lymphatic filariasis; NA, not available; NTD, neglected tropical disease. †Not estimated for Buruli ulcer.
1These authors contributed equally to this article.
Page created: July 02, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.